Hikma Pharmaceuticals PLC (LON: HIK)
London
· Delayed Price · Currency is GBP · Price in GBp1,905.00
+33.00 (1.76%)
Nov 22, 2024, 10:38 AM BST
Hikma Pharmaceuticals Ratios and Metrics
Market cap in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 4,151 | 3,955 | 3,418 | 5,136 | 5,803 | 4,824 | Upgrade
|
| Market Cap Growth | 0.43% | 15.72% | -33.45% | -11.50% | 20.30% | 16.44% | Upgrade
|
| Enterprise Value | 4,966 | 4,766 | 4,383 | 5,569 | 6,208 | 5,109 | Upgrade
|
| Last Close Price | 18.72 | 17.34 | 14.65 | 20.44 | 22.82 | 17.70 | Upgrade
|
| PE Ratio | 18.60 | 25.99 | 21.01 | 15.32 | 17.21 | 11.72 | Upgrade
|
| Forward PE | 10.43 | 10.80 | 9.64 | 14.20 | 18.48 | 17.88 | Upgrade
|
| PS Ratio | 1.73 | 1.75 | 1.64 | 2.72 | 3.38 | 2.89 | Upgrade
|
| PB Ratio | 2.29 | 2.28 | 1.92 | 2.82 | 3.69 | 3.00 | Upgrade
|
| P/TBV Ratio | 4.45 | 4.59 | 4.07 | 4.45 | 6.29 | 4.98 | Upgrade
|
| P/FCF Ratio | 12.20 | 11.48 | 10.51 | 14.11 | 27.13 | 18.10 | Upgrade
|
| P/OCF Ratio | 9.08 | 8.29 | 7.77 | 10.90 | 17.07 | 13.54 | Upgrade
|
| PEG Ratio | 1.58 | 1.55 | 2.10 | 1.49 | 0.68 | 0.62 | Upgrade
|
| EV/Sales Ratio | 2.08 | 2.11 | 2.10 | 2.95 | 3.62 | 3.07 | Upgrade
|
| EV/EBITDA Ratio | 7.27 | 7.68 | 7.88 | 10.50 | 12.96 | 11.59 | Upgrade
|
| EV/EBIT Ratio | 8.80 | 9.81 | 10.61 | 13.44 | 15.69 | 13.92 | Upgrade
|
| EV/FCF Ratio | 14.60 | 13.83 | 13.47 | 15.30 | 29.02 | 19.17 | Upgrade
|
| Debt / Equity Ratio | 0.55 | 0.54 | 0.60 | 0.34 | 0.43 | 0.32 | Upgrade
|
| Debt / EBITDA Ratio | 1.48 | 1.47 | 1.88 | 1.16 | 1.40 | 1.16 | Upgrade
|
| Debt / FCF Ratio | 2.97 | 2.71 | 3.27 | 1.72 | 3.19 | 1.94 | Upgrade
|
| Asset Turnover | 0.64 | 0.63 | 0.57 | 0.60 | 0.58 | 0.59 | Upgrade
|
| Inventory Turnover | 1.75 | 1.76 | 1.70 | 1.72 | 1.70 | 2.02 | Upgrade
|
| Quick Ratio | 0.89 | 0.82 | 1.05 | 1.31 | 1.05 | 0.82 | Upgrade
|
| Current Ratio | 1.66 | 1.57 | 1.86 | 2.06 | 1.87 | 1.26 | Upgrade
|
| Return on Equity (ROE) | 12.88% | 8.81% | 8.28% | 18.20% | 20.11% | 25.46% | Upgrade
|
| Return on Assets (ROA) | 9.40% | 8.46% | 7.04% | 8.24% | 8.37% | 8.18% | Upgrade
|
| Return on Capital (ROIC) | 12.55% | 11.33% | 9.23% | 10.97% | 11.45% | 11.80% | Upgrade
|
| Earnings Yield | 5.37% | 3.77% | 4.57% | 6.05% | 5.44% | 7.61% | Upgrade
|
| FCF Yield | 8.11% | 8.71% | 9.52% | 7.09% | 3.69% | 5.53% | Upgrade
|
| Dividend Yield | 3.39% | 3.26% | 3.17% | 1.95% | 1.60% | 1.88% | Upgrade
|
| Payout Ratio | 55.79% | 72.11% | 66.49% | 28.50% | 25.29% | 19.96% | Upgrade
|
| Buyback Yield / Dilution | -0.59% | 1.13% | 3.47% | 2.10% | 2.06% | -0.41% | Upgrade
|
| Total Shareholder Return | 2.80% | 4.39% | 6.65% | 4.05% | 3.66% | 1.46% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.